These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 33865423)
1. Classification of endonasal HHT lesions using digital microscopy. Haubner F; Schneider A; Schinke H; Bertlich M; Weiss BG; Canis M; Kashani F Orphanet J Rare Dis; 2021 Apr; 16(1):182. PubMed ID: 33865423 [TBL] [Abstract][Full Text] [Related]
2. Pentraxin 3 level is elevated in hereditary hemorrhagic telangiectasia and reflects the severity of disease-associated epistaxis. Steineger J; Ueland T; Aukrust P; Michelsen A; Osnes T; Heimdal K; Dheyauldeen S Laryngoscope; 2019 Jan; 129(1):E44-E49. PubMed ID: 30329172 [TBL] [Abstract][Full Text] [Related]
3. Correlation of severity of epistaxis with nasal telangiectasias in hereditary hemorrhagic telangiectasia (HHT) patients. Pagella F; Colombo A; Matti E; Giourgos G; Tinelli C; Olivieri C; Danesino C Am J Rhinol Allergy; 2009; 23(1):52-8. PubMed ID: 19379613 [TBL] [Abstract][Full Text] [Related]
4. Quality of life in patients with hereditary haemorrhagic telangiectasia (HHT). Zarrabeitia R; Fariñas-Álvarez C; Santibáñez M; Señaris B; Fontalba A; Botella LM; Parra JA Health Qual Life Outcomes; 2017 Jan; 15(1):19. PubMed ID: 28114930 [TBL] [Abstract][Full Text] [Related]
5. Morphology and distribution of nasal telangiectasia in HHT-patients with epistaxis. Folz BJ; Wollstein AC; Lippert BM; Werner JA Am J Rhinol; 2005; 19(1):65-70. PubMed ID: 15794077 [TBL] [Abstract][Full Text] [Related]
6. TIMolol nasal spray as a treatment for epistaxis in hereditary hemorrhagic telangiectasia (HHT) - Study protocol of the prospective, randomized, double-blind, controlled cross-over TIM-HHT trial. Andorfer KEC; Seebauer CT; Koller M; Zeman F; Berneburg M; Fischer R; Vielsmeier V; Bohr C; Kühnel TS Clin Hemorheol Microcirc; 2022; 80(3):307-315. PubMed ID: 34864649 [TBL] [Abstract][Full Text] [Related]
7. Plasma VEGF - a candidate biomarker for response to treatment with bevacizumab in HHT patients. Liu DT; Frohne A; Koenighofer M; Frei K; Lucas T; Riss D; Parzefall T Rhinology; 2020 Feb; 58(1):18-24. PubMed ID: 31681913 [TBL] [Abstract][Full Text] [Related]
8. The effects of epistaxis on health-related quality of life in patients with hereditary hemorrhagic telangiectasia. Merlo CA; Yin LX; Hoag JB; Mitchell SE; Reh DD Int Forum Allergy Rhinol; 2014 Nov; 4(11):921-5. PubMed ID: 25145809 [TBL] [Abstract][Full Text] [Related]
9. Sinonasal quality of life outcomes following laser treatment of epistaxis related to hereditary hemorrhagic telangiectasia. Kuan EC; Peng KA; Thompson CF; Suh JD; Wang MB Lasers Med Sci; 2017 Apr; 32(3):527-531. PubMed ID: 28116537 [TBL] [Abstract][Full Text] [Related]
10. FID Score: an effective tool in Hereditary Haemorrhagic Telangiectasia - related epistaxis. Pagella F; Maiorano E; Matti E; Tinelli C; De Silvestri A; Ugolini S; Lizzio R; Olivieri C; Pusateri A; Spinozzi G Rhinology; 2020 Oct; 58(5):516-521. PubMed ID: 32584331 [TBL] [Abstract][Full Text] [Related]
11. Oral itraconazole for epistaxis in hereditary hemorrhagic telangiectasia: a proof of concept study. Kroon S; Snijder RJ; Hosman AE; Vorselaars VMM; Disch FJM; Post MC; Mager JJ Angiogenesis; 2021 May; 24(2):379-386. PubMed ID: 33211216 [TBL] [Abstract][Full Text] [Related]
12. Cauterization for epistaxis in hereditary hemorrhagic telangiectasia. Dabiri J; Fakhoury R; Choufani G; Mine B; Hassid S B-ENT; 2016; 12(1):9-16. PubMed ID: 27097388 [TBL] [Abstract][Full Text] [Related]
13. Management of epistaxis in hereditary haemorrhagic telangiectasia (HHT) patients using pulsed dye laser and the effect of withholding treatment during the COVID pandemic. Jiang Y; Dennis SC; Brewin MP Lasers Med Sci; 2022 Oct; 37(8):3147-3153. PubMed ID: 35635649 [TBL] [Abstract][Full Text] [Related]
14. New classification of nasal vasculature patterns in hereditary hemorrhagic telangiectasia. Mahoney EJ; Shapshay SM Am J Rhinol; 2006; 20(1):87-90. PubMed ID: 16539301 [TBL] [Abstract][Full Text] [Related]
15. Septectomy and septal dermoplasty for the treatment of severe transfusion-dependent epistaxis in patients with hereditary hemorrhagic telangiectasia and septal perforation. Lesnik GT; Ross DA; Henderson KJ; Joe JK; Leder SB; White RI Am J Rhinol; 2007; 21(3):312-5. PubMed ID: 17621815 [TBL] [Abstract][Full Text] [Related]
16. A review on clinical management and pharmacological therapy on hereditary haemorrhagic telangiectasia (HHT). Zarrabeitia R; Albiñana V; Salcedo M; Señaris-Gonzalez B; Fernandez-Forcelledo JL; Botella LM Curr Vasc Pharmacol; 2010 Jul; 8(4):473-81. PubMed ID: 19485912 [TBL] [Abstract][Full Text] [Related]
17. The minimal important difference of the epistaxis severity score in hereditary hemorrhagic telangiectasia. Yin LX; Reh DD; Hoag JB; Mitchell SE; Mathai SC; Robinson GM; Merlo CA Laryngoscope; 2016 May; 126(5):1029-32. PubMed ID: 26393959 [TBL] [Abstract][Full Text] [Related]
18. Epistaxis in children and adolescents with hereditary hemorrhagic telangiectasia. Gonzalez CD; Mcdonald J; Stevenson DA; Whitehead KJ; Petersen MG; Presson AP; Ding Q; Wilson KF Laryngoscope; 2018 Jul; 128(7):1714-1719. PubMed ID: 29171658 [TBL] [Abstract][Full Text] [Related]
19. Diode laser in the treatment of epistaxis in patients with hereditary haemorrhagic telangiectasia. Fiorella ML; Lillo L; Fiorella R Acta Otorhinolaryngol Ital; 2012 Jun; 32(3):164-9. PubMed ID: 22767981 [TBL] [Abstract][Full Text] [Related]
20. Sclerotherapy and Topical Nasal Propranolol: An Effective and Safe Therapy for HHT-Epistaxis. Esteban-Casado S; Martín de Rosales Cabrera AM; Usarralde Pérez A; Martínez Simón JJ; Zhan Zhou E; Marcos Salazar MS; Pérez Encinas M; Botella Cubells L Laryngoscope; 2019 Oct; 129(10):2216-2223. PubMed ID: 30908653 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]